Peter Salzmann Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 12 hours ago
Peter Salzmann has an estimated net worth of at least $29.5 million*, as of April 16, 2025. They own 1.2 million shares of IMVT stock. They have sold 614,770 shares of IMVT stock since 2021, for an estimated $11.8 million.
Peter Salzmann $IMVT SEC Form 4 Insider Trading
Peter Salzmann has filed a total of 39 insider trades in $IMVT since 2021. Their most recent trade was a sale of 8,321 shares, made on Apr 16, 2025. Their largest trade was a sale of 125,158 shares, made on Jan 07, 2022. We estimate that they now own 1.2 million shares of $IMVT, worth an estimated $17.7 million.
Insider Trading at $IMVT
There have been a total of 186 insider trades reported at $IMVT since 2021, with 18.8 million shares purchased and 1.2 million shares sold. The most active insider traders in $IMVT stock have been Peter Salzmann, William L. Macias, and Eva Renee Barnett. The most recent trade was a sale of 2,993 shares reported by Eva Renee Barnett (Chief Financial Officer), made on Apr 16, 2025.
History of Insider Stock Trades by Peter Salzmann
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 8,321 | Apr 16, 2025 | April 17, 2025, 4:07 p.m. |
![]() |
Sale | 28,094 | Apr 09, 2025 | April 11, 2025, 4:05 p.m. |
![]() |
Sale | 415 | Jan 15, 2025 | Jan. 17, 2025, 5:04 p.m. |
![]() |
Sale | 8,352 | Jan 15, 2025 | Jan. 17, 2025, 5:04 p.m. |
![]() |
Sale | 5,105 | Jan 08, 2025 | Jan. 10, 2025, 5:11 p.m. |
![]() |
Sale | 16,692 | Nov 20, 2024 | Nov. 22, 2024, 5:08 p.m. |
![]() |
Sale | 9,095 | Oct 16, 2024 | Oct. 18, 2024, 4:31 p.m. |
![]() |
Sale | 4,460 | Oct 09, 2024 | Oct. 11, 2024, 4:02 p.m. |
![]() |
Sale | 598 | Aug 21, 2024 | Aug. 23, 2024, 4:07 p.m. |
![]() |
Sale | 14,470 | Aug 21, 2024 | Aug. 23, 2024, 4:07 p.m. |
![]() |
Sale | 510 | Jul 17, 2024 | July 19, 2024, 5:36 p.m. |
![]() |
Sale | 8,175 | Jul 17, 2024 | July 19, 2024, 5:36 p.m. |
![]() |
Sale | 4,619 | Jul 09, 2024 | July 10, 2024, 5:04 p.m. |
![]() |
Sale | 7,714 | Apr 17, 2024 | April 19, 2024, 5:57 p.m. |
![]() |
Sale | 26,365 | Apr 17, 2024 | April 19, 2024, 5:57 p.m. |
![]() |
Sale | 4,807 | Apr 09, 2024 | April 10, 2024, 4:14 p.m. |
![]() |
Sale | 13,454 | Feb 22, 2024 | Feb. 23, 2024, 5:11 p.m. |
![]() |
Sale | 3,824 | Jan 05, 2024 | Jan. 9, 2024, 5:18 p.m. |
![]() |
Sale | 616 | Nov 22, 2023 | Nov. 24, 2023, 3:55 p.m. |
![]() |
Sale | 15,601 | Nov 22, 2023 | Nov. 24, 2023, 3:55 p.m. |
![]() |
Sale | 4,345 | Oct 05, 2023 | Oct. 6, 2023, 5:10 p.m. |
![]() |
Sale | 894 | Oct 05, 2023 | Oct. 6, 2023, 5:10 p.m. |
![]() |
Sale | 50,866 | Aug 30, 2023 | Sept. 1, 2023, 4:08 p.m. |
![]() |
Sale | 5,908 | Aug 30, 2023 | Sept. 1, 2023, 4:08 p.m. |
![]() |
Sale | 91,744 | Aug 14, 2023 | Aug. 16, 2023, 4:11 p.m. |
![]() |
Sale | 11,314 | Aug 14, 2023 | Aug. 16, 2023, 4:11 p.m. |
![]() |
Sale | 101,339 | Aug 07, 2023 | Aug. 8, 2023, 4:44 p.m. |
![]() |
Sale | 3,233 | Jul 12, 2023 | July 13, 2023, 5:11 p.m. |
![]() |
Sale | 3,395 | Apr 18, 2023 | April 19, 2023, 4:09 p.m. |
![]() |
Sale | 4,021 | Jan 11, 2023 | Jan. 13, 2023, 9:21 a.m. |
![]() |
Sale | 2,793 | Oct 13, 2022 | Oct. 17, 2022, 8:57 a.m. |
![]() |
Sale | 1,605 | Sep 28, 2022 | Sept. 29, 2022, 5:06 p.m. |
![]() |
Sale | 1,644 | Aug 30, 2022 | Sept. 1, 2022, 7:36 a.m. |
![]() |
Sale | 1,528 | Jul 27, 2022 | July 29, 2022, 7:36 a.m. |
![]() |
Sale | 1,376 | Jun 29, 2022 | July 1, 2022, 7:05 a.m. |
![]() |
Sale | 1,471 | May 24, 2022 | May 25, 2022, 4:23 p.m. |
![]() |
Sale | 1,622 | Apr 27, 2022 | April 29, 2022, 7:05 a.m. |
![]() |
Sale | 19,227 | Mar 24, 2022 | April 14, 2022, 7:16 a.m. |
![]() |
Sale | 125,158 | Jan 07, 2022 | Jan. 11, 2022, 11:49 a.m. |
$IMVT Executives and Stock Owners with Insider Trades
-
Peter Salzmann, Chief Executive Officer
-
William L. Macias, Chief Medical Officer
-
Eva Renee Barnett, Chief Financial Officer
-
Mark S. Levine, Chief Legal Officer
-
Julia G. Butchko, Chief Development Officer
-
Julia G. Butchko, Chief Dev. & Tech. Officer
-
Michael Geffner, Chief Medical Officer
-
Jay S Stout, Chief Technology Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.